3SBio, Inc., a biotechnology company, focuses on the research, development, manufacture, and marketing of biopharmaceutical products primarily in the People’s Republic of China. Its product candidates are designed to address unmet medical needs in nephrology, oncology, supportive cancer care, inflammation, and.. Read More

aaiPharma, Inc. operates as a science-based pharmaceutical company primarily in the United States and Europe. The company focuses on acquiring, improving, and marketing branded medicines in pain management and critical care. Its pain management products include Roxicodone tablets and immediate release oral.. Read More

Aastrom Biosciences, Inc. engages in developing autologous cell products for the repair or regeneration of human tissue. Its proprietary tissue repair cell (TRC) technology involves the use of a patient's own cells to manufacture products to treat a range of chronic diseases and serious injuries. The company’s.. Read More

Abraxis Bioscience, Inc., a biotechnology company, engages in the discovery, development, and delivery of next-generation therapeutics and core technologies that offer treatments for cancer and other critical illnesses. The company’s product pipeline includes clinical oncology and cardiovascular product.. Read More

ACADIA Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Its developing products include Pimavanserin for the treatment of Parkinson’s disease psychosis in Phase III.. Read More

Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, develops and commercializes drug candidates that are in late-stage clinical development based on active pharmaceutical ingredients in the therapeutic areas of respiratory disease and oncology. It operates in two.. Read More

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of HIV infection and chronic hepatitis C; and antibacterials for the treatment of.. Read More

Acorda Therapeutics, Inc., a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple sclerosis (MS), spinal cord injury, and other disorders of the central nervous system in the United.. Read More

A development stage Company focusing on investing and commercializing novel technology platforms concerning the Life Sciences sector.

Adeona Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary late-stage drug candidates for the treatment of neurologic and autoimmune diseases. It has five clinical stage drug candidates addressing various markets, including multiple sclerosis, fibromyalgia, dry age related macular.. Read More

Adherex Technologies, Inc., together with its subsidiaries, operates as a development stage biopharmaceutical company with a portfolio of product candidates under development for use in the treatment of cancer. The company’s clinical product portfolio includes Eniluracil, a dihydropyrimidine dehydrogenase.. Read More

Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research.. Read More

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs in the areas of infectious disease, oncology, and inflammation. The company has a worldwide license from Abbott Laboratories to develop and commercialize its lead candidate,.. Read More

Advanced Tissue Sciences, Inc. announced that its Chapter 11 Liquidating Plan became effective on March 31, 2003. As a result of the Plan, the stock of ATS was cancelled and its former stockholders now hold non-trading interests in the ATS Liquidating Trust. The Bankruptcy Court also approved the sale of its.. Read More

Advaxis, Inc., a development stage biotechnology company, engages in the research and development of new cancer-fighting techniques. It develops cancer vaccines targeting cervical, breast, prostate, ovarian, lung, and other cancers. The company’s products in development include Lovaxin C, a Phase I/II trial.. Read More

ADVENTRX Pharmaceuticals, Inc., a biopharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease in the United States. Its products include ANX-530, a novel emulsion formulations of chemotherapy drugs.. Read More

Aeterna Zentaris, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for endocrine therapy and oncology. Its product development activities focus on various therapeutic areas, primarily luteinizing hormone releasing hormone (LHRH) antagonists, and signal.. Read More

Affymax, Inc., a biopharmaceutical company, engages in the development of peptide-based drug candidates to enhance the treatment of serious and life-threatening conditions. The company’s lead product candidate includes Hematide, which is designed to treat anemia associated with chronic renal failure and cancer... Read More

Alfacell Corporation, a development stage company, engages in the discovery and development of therapeutic drugs for the treatment of cancer and other pathological conditions. Its primary drug product candidate, ONCONASE, is in phase IIIb registration trial for the treatment of unresectable (inoperable) malignant.. Read More

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of various therapeutics based on RNA interference (RNAi). Its lead RNAi therapeutic program includes ALN-RSV01, a phase II human clinical trial product for the treatment of respiratory syncytial virus (RSV) infection. It has.. Read More

Alseres Pharmaceuticals, Inc., a biotechnology company, develops therapeutic and diagnostic products primarily for disorders in the central nervous system. The company’s product pipeline is based on proprietary technology platforms, such as regenerative therapeutics program, which focuses on nerve repair and.. Read More

Altus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of oral and injectable protein therapeutics for gastrointestinal and metabolic disorders. The company’s products include ALTU-135, a Phase II completed clinical trial product is an orally-administered enzyme.. Read More

Amarillo Biosciences, Inc., a biotechnology company, engages in the research and development of utilization of low-dose, orally administered interferon as a treatment for various conditions comprising chronic cough, influenza, and opportunistic infections in patients who are HIV positive. The company has.. Read More

Amazon Biotech, Inc., a development stage company, engages in the research and development of natural drugs in the United States. It owns rights to an investigational drug candidate, AMZ0026, which is a naturally derived pharmaceutical drug compound made up of plant substances for the treatment of HIV/AIDS. The.. Read More

American Oriental Bioengineering, Inc., together with its subsidiaries, engages in the development, manufacture, and commercialization of a range of pharmaceutical and healthcare products. It offers prescription pharmaceutical products, over-the-counter pharmaceutical products, and nutraceutical products. The.. Read More

Amgen, Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation, and oncology. The company’s.. Read More

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. The Pharmacological chaperone technology involves the use.. Read More

Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States. It sells BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection for the treatment of patients with.. Read More

Anadys Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing medicines in the areas of hepatitis C and oncology. It develops ANA598, a small-molecule non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C; and ANA773, an oral toll-like receptor 7 agonist prodrug for.. Read More

Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management. Its portfolio of products includes Zingo, which is approved for use in children 3 to 18 years of age for the reduction of pain associated with venipunctures; and Adlea,.. Read More

AngioGenex, Inc., a development stage biopharmaceutical company, engages in the research to develop anti-cancer strategies using the field of antiangiogenesis. Its programs focus on the discovery and development of orally active anti-cancer drugs that act by modulating the action of the Id proteins; the.. Read More

Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair primarily in the United States, Europe, and Turkey. Its products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer.. Read More

Antigenics, Inc., a biotechnology company, engages in the research and development of technologies and product candidates to treat cancers and infectious diseases. Its investigational product portfolio includes Oncophage (vitespen), a patient-specific therapeutic cancer vaccine approved in Russia; QS-21, an.. Read More

ARIAD Pharmaceuticals, Inc., together with its subsidiaries, discovers and develops medicines to treat cancers by regulating cell signaling with small molecules in the United States and Europe. The company’s cancer product candidate includes deforolimus, a potent protein mTOR inhibitor for the treatment of solid.. Read More

Arno Therapeutics, Inc., a development-stage company, engages in developing and commercializing products for the treatment of cancer. The company’s lead compound, AR-67, is a Phase I clinical trial novel anti-cancer agent. It also develops AR-12 and AR-42, which are preclinical stage oncology products. The company is based in the Fairfield, New Jersey.

Artes Medical, Inc., a medical technology company, focuses on the developing, manufacturing, and commercializing injectable aesthetic products for the dermatology and plastic surgery markets in the United States. It offers ArteFill, a non-resorbable aesthetic injectable implant for the correction of facial.. Read More

ASI Technology Corporation operates as a specialty finance and technology development company. It provides real estate, corporate, and various other loans. The company’s real estate loans are advanced to bridge finance projects during the development and permitting phase. In addition, ASI Technology focuses on.. Read More

Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic product candidates in multiple disease areas in the United States. Its product pipeline includes ATHX-105, a Phase I clinical trial product for the treatment of obesity. The company also develops orally active.. Read More

Auriga Laboratories, Inc., a specialty pharmaceutical company, engages in the development, commercialization, and licensing of pharmaceutical products in the areas of respiratory, dermatology, and anti-infective therapeutic categories. The company's product line includes Extendryl for the treatment of cough,.. Read More

AutoImmune, Inc., a development stage company, develops products for the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. It offers a dietary supplement under Colloral, The Collagen Solution, and Vital 3 brand names for treating the signs and symptoms of rheumatoid arthritis... Read More

AutoImmune, Inc., a development stage company, develops products for the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. It offers a dietary supplement under Colloral, The Collagen Solution, and Vital 3 brand names for treating the signs and symptoms of rheumatoid arthritis... Read More